HERON THERAPEUTICS, INC. /DE/ Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Heron Therapeutics, Inc. /De/ Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.85M, a 80.6% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$28M, a 76.6% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2023 was -$111M, a 39.3% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2022 was -$182M, a 17.5% increase from 2021.
  • Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2021 was -$221M, a 2.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28M -$4.85M +$20.2M +80.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$48.1M -$9.24M +$32.8M +78% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$81M -$3.16M +$29.6M +90.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$111M -$10.7M +$9.15M +46% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$120M -$25M +$16.9M +40.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$137M -$42.1M +$14.3M +25.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$151M -$32.8M +$31.1M +48.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$182M -$19.9M +$34.8M +63.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$217M -$41.9M +$10.5M +20% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$227M -$56.4M +$4.66M +7.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$232M -$63.9M -$11.3M -21.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$221M -$54.6M +$7.64M +12.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$228M -$52.4M +$5.82M +10% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$234M -$61M -$5.83M -10.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$228M -$52.6M -$1.04M -2.01% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$227M -$62.3M -$4.36M -7.53% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$223M -$58.2M -$24.6M -73.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$198M -$55.2M -$4.97M -9.89% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 -$193M -$51.6M +$11.4M +18.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 -$205M -$57.9M -$8.36M -16.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$196M -$33.6M +$4.75M +12.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$201M -$50.2M -$11.6M -29.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$190M -$63M -$10.7M -20.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$179M -$49.6M +$12.9M +20.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$192M -$38.3M +$3.52M +8.41% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$195M -$38.7M +$4.13M +9.65% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$199M -$52.3M -$1.94M -3.85% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$197M -$62.5M -$14.5M -30.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-22
Q3 2017 -$183M -$41.9M +$6.64M +13.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-22
Q2 2017 -$190M -$42.8M +$427K +0.99% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-22
Q1 2017 -$190M -$50.3M -$16.9M -50.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-22
Q4 2016 -$173M -$48M -$16.7M -53.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$156M -$48.5M -$25.8M -114% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 -$131M -$43.2M -$20.1M -87.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 -$110M -$33.4M -$12.9M -62.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 -$97.6M -$31.2M -$10.6M -51.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$87M -$22.7M -$3.48M -18.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$83.5M -$23.1M -$4.1M -21.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$79.4M -$20.6M -$3.03M -17.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 -$76.4M -$20.6M -$6.58M -46.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-19
Q3 2014 -$69.8M -$19.2M -$6.32M -49.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-19
Q2 2014 -$63.5M -$19M -$3.6M -23.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-19
Q1 2014 -$59.9M -$17.5M -$4.59M -35.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-19
Q4 2013 -$55.3M -$14M -$6.31M -81.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$49M -$12.9M -$6.75M -110% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$42.2M -$15.4M -$10.8M -237% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$31.4M -$13M $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$31.4M -$7.74M -$3.48M -81.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$27.9M -$6.12M -$1.92M -45.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-07
Q2 2012 -$26M -$4.57M -$2.64M -136% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-07
Q1 2012 -$23.3M -$13M -$11.5M -813% Jan 1, 2012 Mar 31, 2012 10-K 2015-03-13
Q4 2011 -$11.8M -$4.26M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 -$4.2M -$2.53M -151% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 -$1.93M +$1.65M +46.1% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 -$1.42M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q3 2010 -$1.67M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$3.58M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.